<?xml version="1.0" encoding="UTF-8"?>
<ref id="B116-pharmaceuticals-13-00444">
 <label>116.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Ren</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Qu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>X.</given-names>
   </name>
  </person-group>
  <article-title>A bufadienolide-loaded submicron emulsion for oral administration: Stability, antitumor efficacy and toxicity</article-title>
  <source>Int. J. Pharm.</source>
  <year>2015</year>
  <volume>479</volume>
  <fpage>52</fpage>
  <lpage>62</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijpharm.2014.12.054</pub-id>
  <?supplied-pmid 25545797?>
  <pub-id pub-id-type="pmid">25545797</pub-id>
 </element-citation>
</ref>
